Study reveals how syncytia formation induced by SARS-CoV-2 virus helps evade immune responses

Medical News: A new study by an international team of scientists sheds light on how the SARS-CoV-2 virus, responsible for the COVID-19 pandemic, is able to evade critical immune defenses. The study explores the role of "syncytia formation," a process where infected cells merge together, helping the virus resist key immune responses like interferons and neutralizing antibodies.

Study reveals how syncytia formation induced by SARS-CoV-2 virus helps evade immune responses

The research covered in this Medical News report, was conducted by scientists from several prestigious institutions, including the U.S. National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), Texas Biomedical Research Institute, and the U.S. Food and Drug Administration (FDA). Their work provides valuable insights into why certain variants of the virus continue to circulate; even as global vaccination efforts expand.
 
What Are Syncytia, and Why Do They Matter?
In simpler terms, syncytia are giant cells formed when individual cells infected by the virus fuse together. While syncytia formation is common in many viral infections, SARS-CoV-2 seems to have a unique advantage through this process, according to this article. By merging cells, the virus can hide from interferons, proteins that are normally responsible for limiting viral replication during the early stages of infection.
 
The study highlights how syncytia formation not only helps the virus resist these early immune defenses but also reduces the effectiveness of neutralizing antibodies - those special proteins generated by the immune system or vaccines to block the virus from infecting cells.
 
Key Findings from the Research
The researchers experimented with different versions of the SARS-CoV-2 virus, including those that were altered to either promote or reduce syncytia formation. They observed that the syncytia-producing strains of the virus were much better at avoiding immune defenses compared to strains that did not produce syncytia.

This ability to evade the immune response was tested in various ways, including using cultured cells from the human airway, animal models, and even genetically engineered viruses similar to SARS-CoV-2. In all scenarios, viruses that formed syncytia were able to reproduce more efficiently in the presence of interferons.

One of the most striking findings from the study is how amino acid changes in the spike protein of the virus can enhance syncytia formation. This is particularly important because the spike protein is the part of the virus that vaccines target. Variants like Delta and Omicron, which have undergone changes in this region, show a higher capability for syncytia formation, which might explain why they are more transmissible and resistant to some immune responses.
 
The Role of Interferons and Antibodies
Interferons are crucial for the body’s early immune response, especially in unvaccinated individuals. They act as a first line of de fense, signaling the immune system to take action against viruses. However, the study found that syncytia formation allows SARS-CoV-2 to become resistant to interferon-based defenses.

In the laboratory, scientists tested how well the virus could resist interferons by exposing both normal and genetically modified strains to these proteins. The syncytia-forming strains continued to thrive even when exposed to high levels of interferons, proving their advantage in immune evasion.
 
Additionally, the study explored how syncytia formation impacts neutralizing antibodies, which are central to the body’s defense after vaccination or infection. The research found that antibodies were less effective at blocking the virus when it had already formed syncytia. This suggests that once the virus is in this stage, even antibodies from a previous infection or vaccine may struggle to fully neutralize the infection.
 
Why Syncytia-Forming Variants are Still Circulating
Throughout the pandemic, variants such as Delta and Omicron have emerged, showing increased resistance to both vaccines and naturally developed immunity. A key reason for this, according to the researchers, is the virus's ability to form syncytia. By merging cells, the virus can bypass much of the body's immune defense, explaining why variants that are good at forming syncytia continue to dominate.
 
Syncytia formation also complicates vaccine efforts. While current vaccines target the spike protein and can prevent severe disease, the virus’s ability to form syncytia means that it can continue spreading, especially in populations with lower vaccination rates or where immunity is waning.
 
Interestingly, the study also found that while syncytia formation helps the virus evade the immune system, it does slow down the virus's ability to create new infectious particles. This might seem like a disadvantage, but in an immune environment where interferons and antibodies are present, the benefits of syncytia formation outweigh the drawbacks.
 
Implications for Future Treatments and Vaccines
These findings have significant implications for how we understand viral evolution and design future treatments. Since the formation of syncytia plays a crucial role in immune evasion, targeting this process could be a key strategy in developing better antiviral therapies.
 
The researchers suggest that by disrupting syncytia formation, it may be possible to make the virus more susceptible to both natural and vaccine-induced immunity. For instance, drugs that prevent cell fusion might be able to stop the virus from forming these giant cells, thereby exposing it to the body’s immune responses.
 
Conclusion
The study provides a deeper understanding of how SARS-CoV-2 evolves and continues to pose challenges to global health. By highlighting the role of syncytia formation, it opens the door to new strategies for controlling the virus, especially as it continues to mutate.
 
In conclusion, the ability of SARS-CoV-2 to form syncytia gives it a significant advantage in avoiding immune responses, particularly interferons and antibodies. This explains why syncytia-forming variants like Delta and Omicron have been so successful in spreading, despite the global push for vaccines. Future research and treatments could focus on inhibiting this process, potentially leading to better outcomes for patients and more effective public health strategies.
 
The study findings were published on a preprint server and are currently being peer-reviewed for publication in the journal: Nature Communications.
https://www.researchsquare.com/article/rs-3846435/v1
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/israeli-study-reveals-p681-residue-as-key-residue-dictating-cell-fusion-and-syncytia-formation-in-sars-cov-2-variants
 
https://www.thailandmedical.news/news/university-of-south-florida-study-shows-that-palmitoylation-of-sars-cov-2-spike-protein-is-essential-for-cell-entry-and-the-formation-of-syncytia